Establishment Labs (NASDAQ:ESTA) Trading Down 8.9% – Here’s What Happened

Establishment Labs Holdings Inc. (NASDAQ:ESTA)’s stock price fell 8.9% during trading on Tuesday . The stock traded as low as $28.50 and last traded at $28.51. 347,841 shares traded hands during trading, a decline of 20% from the average session volume of 433,839 shares. The stock had previously closed at $31.30.

Wall Street Analyst Weigh In

Separately, Stephens reissued an “overweight” rating and issued a $52.00 target price on shares of Establishment Labs in a research note on Thursday, March 6th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, Establishment Labs currently has a consensus rating of “Moderate Buy” and an average target price of $57.40.

Establishment Labs Price Performance

The stock has a market capitalization of $787.78 million, a price-to-earnings ratio of -10.59 and a beta of 0.77. The business’s 50 day simple moving average is $36.63 and its 200-day simple moving average is $40.52. The company has a debt-to-equity ratio of 5.94, a quick ratio of 2.29 and a current ratio of 3.62.

Establishment Labs (NASDAQ:ESTA) last issued its quarterly earnings results on Wednesday, February 26th. The company reported ($0.98) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.64) by ($0.34). The firm had revenue of $44.51 million for the quarter, compared to analyst estimates of $44.45 million. Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. Research analysts anticipate that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the business. Quarry LP purchased a new stake in shares of Establishment Labs during the fourth quarter worth $27,000. R Squared Ltd acquired a new stake in Establishment Labs in the 4th quarter worth approximately $36,000. KLP Kapitalforvaltning AS acquired a new stake in shares of Establishment Labs in the fourth quarter worth $161,000. Hood River Capital Management LLC lifted its position in Establishment Labs by 236.4% during the 4th quarter. Hood River Capital Management LLC now owns 5,920 shares of the company’s stock worth $273,000 after acquiring an additional 4,160 shares during the last quarter. Finally, Handelsbanken Fonder AB lifted its position in shares of Establishment Labs by 32.3% during the 4th quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company’s stock worth $378,000 after purchasing an additional 2,000 shares during the last quarter. 72.91% of the stock is owned by institutional investors and hedge funds.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.